Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 447.86M | 623.98M | 725.35M | 496.69M | 445.19M |
Gross Profit | 162.31M | 224.67M | 125.21M | -2.92M | 43.77M |
EBITDA | 30.90M | 113.06M | 110.08M | -117.87M | 50.20M |
Net Income | 4.65M | 78.89M | 100.95M | -151.56M | 46.90M |
Balance Sheet | |||||
Total Assets | 332.61M | 598.19M | 666.19M | 560.40M | 704.23M |
Cash, Cash Equivalents and Short-Term Investments | 31.60M | 107.64M | 143.61M | 95.12M | 116.28M |
Total Debt | 18.94M | 723.00K | 98.85M | 109.82M | 117.83M |
Total Liabilities | 123.16M | 161.92M | 266.62M | 249.90M | 232.37M |
Stockholders Equity | 209.45M | 436.27M | 398.21M | 309.13M | 470.72M |
Cash Flow | |||||
Free Cash Flow | 22.69M | 75.22M | 63.72M | -8.76M | 36.18M |
Operating Cash Flow | 45.68M | 109.86M | 97.63M | 15.83M | 54.96M |
Investing Cash Flow | -46.74M | -18.00M | -29.62M | -19.22M | -15.28M |
Financing Cash Flow | -75.52M | -125.66M | -18.99M | -17.98M | -15.62M |
In the first half of 2025, the CPH Group reported stable financial results with sales of CHF 176 million and an EBITDA margin of 17.2%. Despite a challenging economic environment marked by geopolitical tensions and currency fluctuations, the company advanced its global expansion strategy through acquisitions in Israel, Hungary, and Canada. The integration of these acquisitions is proceeding as planned, contributing to the company’s market positioning in high-growth regions. The outlook for the second half of the year remains confident, with expectations of slightly higher operating and net results compared to the previous year.
The CPH Group has successfully completed the acquisition of SiliCycle, a Canadian company, through its chemical division, Zeochem. This acquisition is part of CPH Group’s global expansion strategy, enhancing its product portfolio and strengthening its market position in high-growth areas, now operating at 15 locations worldwide.
The CPH Group’s Chemistry division, Zeochem, has announced the acquisition of SiliCycle in Canada, a leading producer of chromatography gels for the pharmaceutical industry. This acquisition is part of CPH Group’s strategy to expand its product portfolio and strengthen its market position globally, with the integration expected to enhance synergies in production and distribution.